| Product Code: ETC9553647 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Sweden`s drug and gene delivery systems import market continued to see steady growth, with key exporting countries being Denmark, Belgium, Germany, Netherlands, and Italy. The low Herfindahl-Hirschman Index (HHI) concentration indicates a competitive market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 4.69%, with a notable growth spurt of 17.54% from 2023 to 2024. This signals a positive outlook for the industry, driven by innovation and collaboration between Sweden and its top trading partners in advancing drug and gene delivery technologies.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Drug and Gene Delivery Systems Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, 2022 & 2032F |
3.3 Sweden Drug and Gene Delivery Systems Market - Industry Life Cycle |
3.4 Sweden Drug and Gene Delivery Systems Market - Porter's Five Forces |
3.5 Sweden Drug and Gene Delivery Systems Market Revenues & Volume Share, By Delivery System, 2022 & 2032F |
3.6 Sweden Drug and Gene Delivery Systems Market Revenues & Volume Share, By Gene Delivery Systems, 2022 & 2032F |
3.7 Sweden Drug and Gene Delivery Systems Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 Sweden Drug and Gene Delivery Systems Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Sweden Drug and Gene Delivery Systems Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Sweden |
4.2.2 Technological advancements in drug and gene delivery systems |
4.2.3 Growing demand for personalized medicine |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug and gene delivery systems |
4.3.2 High costs associated with research and development of advanced delivery systems |
4.3.3 Limited reimbursement policies for innovative delivery technologies |
5 Sweden Drug and Gene Delivery Systems Market Trends |
6 Sweden Drug and Gene Delivery Systems Market, By Types |
6.1 Sweden Drug and Gene Delivery Systems Market, By Delivery System |
6.1.1 Overview and Analysis |
6.1.2 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Delivery System, 2022 - 2032F |
6.1.3 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Drug Delivery Systems, 2022 - 2032F |
6.2 Sweden Drug and Gene Delivery Systems Market, By Gene Delivery Systems |
6.2.1 Overview and Analysis |
6.2.2 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Viral Gene Delivery, 2022 - 2032F |
6.2.3 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Non-viral Gene Delivery, 2022 - 2032F |
6.2.4 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Combined Hybrid System, 2022 - 2032F |
6.3 Sweden Drug and Gene Delivery Systems Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Oral, 2022 - 2032F |
6.3.3 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.3.4 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3.5 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Transdermal, 2022 - 2032F |
6.3.6 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Ocular, 2022 - 2032F |
6.3.7 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Nasal, 2022 - 2032F |
6.4 Sweden Drug and Gene Delivery Systems Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Infectious Diseases, 2022 - 2032F |
6.4.3 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Oncology, 2022 - 2032F |
6.4.4 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Ophthalmology, 2022 - 2032F |
6.4.5 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Urology, 2022 - 2032F |
6.4.6 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.4.7 Sweden Drug and Gene Delivery Systems Market Revenues & Volume, By CNS, 2022 - 2032F |
7 Sweden Drug and Gene Delivery Systems Market Import-Export Trade Statistics |
7.1 Sweden Drug and Gene Delivery Systems Market Export to Major Countries |
7.2 Sweden Drug and Gene Delivery Systems Market Imports from Major Countries |
8 Sweden Drug and Gene Delivery Systems Market Key Performance Indicators |
8.1 Adoption rate of novel drug and gene delivery technologies in healthcare facilities |
8.2 Number of clinical trials utilizing advanced delivery systems in Sweden |
8.3 Investment in research and development of drug delivery technologies |
9 Sweden Drug and Gene Delivery Systems Market - Opportunity Assessment |
9.1 Sweden Drug and Gene Delivery Systems Market Opportunity Assessment, By Delivery System, 2022 & 2032F |
9.2 Sweden Drug and Gene Delivery Systems Market Opportunity Assessment, By Gene Delivery Systems, 2022 & 2032F |
9.3 Sweden Drug and Gene Delivery Systems Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 Sweden Drug and Gene Delivery Systems Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Sweden Drug and Gene Delivery Systems Market - Competitive Landscape |
10.1 Sweden Drug and Gene Delivery Systems Market Revenue Share, By Companies, 2025 |
10.2 Sweden Drug and Gene Delivery Systems Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here